Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

Completed · Phase 1

Conditions studied: Cerebrovascular Accident

In brief

The purpose of this study is to assess the safety and feasibility of the NeuroFlo™ catheter in treating patients with ischemic stroke whose last time symptom-free was between 8-24 hours prior to treatment. The NeuroFlo device is intended to increase blood flow to the brain and potentially reduce the damage caused by stroke.

Key facts

Study ID

NCT00436592

Run by

CoAxia

People needed

26

Starts

2007-02-01

Expected to finish

2009-01-01

Last updated by the study team

2009-02-05

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ischemic stroke
• NIHSS between 4-20
• Time from symptom onset between 8 and 24 hours

You may not qualify if…

• Hemorrhagic stroke
• Certain types of heart disease
• Kidney disease
• Other conditions the doctor will assess

Where it is running

• UCLA — Los Angeles, California, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Rochester — Rochester, New York, United States
• University of North Carolina — Chapel Hill, North Carolina, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• University of Calgary — Calgary, Alberta, Canada
• University of Alberta — Edmonton, Alberta, Canada
• University of Erlangen — Erlangen, Germany
• University of Essen — Essen, Germany
• CHUV Lausanne — Lausanne, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.